DIA: Driving Insights to Action
Science:Life Sciences
“One of the best questions we can ask is, why?” explains Deborah Collyar, Founder and President of Patient Advocates in Research. “People in industry are beginning to realize that we have reached a tipping point,” suggests Dr. Lode Dewulf, Chief Patient Officer at Servier Group. “The risk of not engaging patients has for the first time become bigger than the risk of engaging patients.” Deborah and Lode serve as Patient Engagement Editors for DIA's Global Forum.
More Episodes
DIA/Tufts CSDD Research: AI Saving Time in Drug Development
2025-01-17
480
2025-01-17
480
DIA: Your Partner in Life Sciences Training and Development
2024-11-06
319
2024-11-06
319
GPP Experts Explain Authorship Algorithm
2024-04-23
280
2024-04-23
280
"Dossier in the Cloud" Democratizing Global Access
2024-04-02
319
2024-04-02
319
DIA: A Place Where You Can Make a Difference
2024-03-28
262
2024-03-28
262
Retiring TGA Head Maps Australia’s Post-Pandemic Future
2023-07-17
398
2023-07-17
398
Patient Engagement: Evolution of Who Knows What, Part 2
2023-06-14
291
2023-06-14
291
Patient Engagement: Evolution of Who Knows What, Part 1
2023-06-12
432
2023-06-12
432
Rwanda Welcomes African Medicines Agency Home
2022-11-30
604
2022-11-30
604
Will Technology Solve the Research “People Problem”?
2022-11-22
377
2022-11-22
377
Why Trans/Nonbinary Research Benefits All Communities
2022-11-18
604
2022-11-18
604
Digital Revolutionizing Data-Driven Reimbursement
2022-10-20
403
2022-10-20
403
China Sets New Record for Local Drug Approvals in 2021
2022-09-15
437
2022-09-15
437
WHO Pilot Formalizes CSA Process to Assist Developers
2022-08-02
430
2022-08-02
430
Get this podcast on your
phone, FREE
